ZimVie Shareholders Receive Final Payout as ARCHIMED Acquisition Concludes

Shareholders Approve Premium Buyout

The publicly traded chapter of ZimVie Inc. has officially closed. The dental technology company completed its acquisition by healthcare-focused private equity firm ARCHIMED in a transaction valued at $730 million. ZimVie shares ceased trading on the NASDAQ exchange in October, with shareholders receiving a final cash distribution of $19 per share—a figure that nearly doubled the stock’s 90-day average price prior to the deal’s announcement.

In a special meeting held on October 10, ZimVie stockholders overwhelmingly voted to approve the acquisition. Trading was halted after the market closed on October 17, with NASDAQ formally suspending the listing on October 21. The transaction concluded on October 20, converting every outstanding share into a $19 cash payment.